Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does LOTEPREDNOL ETABONATE Cause Visual acuity reduced? 10 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Visual acuity reduced have been filed in association with LOTEPREDNOL ETABONATE (Zylet). This represents 0.6% of all adverse event reports for LOTEPREDNOL ETABONATE.

10
Reports of Visual acuity reduced with LOTEPREDNOL ETABONATE
0.6%
of all LOTEPREDNOL ETABONATE reports
0
Deaths
0
Hospitalizations

How Dangerous Is Visual acuity reduced From LOTEPREDNOL ETABONATE?

Of the 10 reports.

Is Visual acuity reduced Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for LOTEPREDNOL ETABONATE. However, 10 reports have been filed with the FAERS database.

What Other Side Effects Does LOTEPREDNOL ETABONATE Cause?

Off label use (255) Eye irritation (211) Vision blurred (179) Eye pain (170) Drug ineffective (168) Ocular hyperaemia (133) Product use in unapproved indication (129) Visual impairment (75) Eye pruritus (71) Intraocular pressure increased (70)

What Other Drugs Cause Visual acuity reduced?

RANIBIZUMAB (1,342) INSULIN LISPRO (1,172) AFLIBERCEPT (993) BELANTAMAB MAFODOTIN (708) BEVACIZUMAB (451) DIMETHYL (440) INSULIN GLARGINE (438) INTERFERON BETA-1A (396) INSULIN HUMAN (393) BROLUCIZUMAB-DBLL (365)

Which LOTEPREDNOL ETABONATE Alternatives Have Lower Visual acuity reduced Risk?

LOTEPREDNOL ETABONATE vs LOTEPREDNOL ETABONATE\TOBRAMYCIN LOTEPREDNOL ETABONATE vs LOTILANER LOTEPREDNOL ETABONATE vs LOVASTATIN LOTEPREDNOL ETABONATE vs LOVAZA LOTEPREDNOL ETABONATE vs LOVENOX

Related Pages

LOTEPREDNOL ETABONATE Full Profile All Visual acuity reduced Reports All Drugs Causing Visual acuity reduced LOTEPREDNOL ETABONATE Demographics